Insider sales by Jason Krantz and CEO Kevin Coop reveal a strategic trim amid a 57% YTD drop, hinting at portfolio hedging rather than panic in Definitive Healthcare.
CEO Kevin Coop’s March 1 sale of 175k shares—tax‑driven, not bearish—shows Definitive Healthcare’s execs still hold long‑term stakes amid a 76% YTD plunge.
Insider sale of Definitive Healthcare shares sparks investor concern. Discover why Krantz’s February 2026 trade could signal short‑term doubts and what to watch for in upcoming filings.